HUYA Bioscience International
PrivateLast Round
Debt
May 3, 2020
Total Funding Raised
$53M
Company Overview
HUYA Bioscience International operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Debt round in May 2020.
HUYA Bioscience International is a biopharmaceutical company that identifies, develops, and commercializes innovative drug candidates originating in China for global markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HUYA Bioscience International Comparables
Compare HUYA Bioscience International with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xynomic Pharmaceuticals | 80% | |
| ArriVent | 78% | |
| Boston Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
HUYA Bioscience International Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 3, 2020 | ||||
| Series B | Apr 22, 2015 | ||||
| VC Round | Apr 2, 2012 | ||||
| Seed | Apr 7, 2009 | ||||
| Corporate Funding | Jan 9, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2024
Monthly visitors increased 462% MoM, from 1.3K to 7.3K.
- Apr 22, 2015
$48M round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 30, 2026
HUYABIO International announced that further pivotal Phase 3 data for HBI-8000 in combination with nivolumab in advanced melanoma was selected for a Late-Breaking presentation in an oral Proffered Paper session at ESMO Congress 2026 in Spain in Oct '26.
For institutional investors. Book with your work email.
HUYA Bioscience International Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HUYA Bioscience International's valuation, stock price, and market status.
Is HUYA Bioscience International a public or private company?
HUYA Bioscience International is a private company.
What is the current stock price of HUYA Bioscience International?
HUYA Bioscience International is a private company, so its shares have no public market price. Caplight tracks HUYA Bioscience International's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HUYA Bioscience International worth (valuation)?
Valuation information for HUYA Bioscience International is not publicly available.
Can I buy HUYA Bioscience International stock?
HUYA Bioscience International shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HUYA Bioscience International's last funding round?
HUYA Bioscience International's most recent funding round was Debt on May 3, 2020.
Who are the main investors in HUYA Bioscience International?
Investor information for HUYA Bioscience International is not publicly disclosed.
Will HUYA Bioscience International IPO soon?
No public IPO plans have been announced for HUYA Bioscience International.
How can I track HUYA Bioscience International secondary market activity?
Caplight tracks bids, offers, and trades in HUYA Bioscience International's shares on secondary markets.